Renal replacement therapy in cryoglobulinaemic nephritis

A. Tarantino, G. Moroni, G. Banfi, C. Manzoni, S. Segagni, C. Ponticelli

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Seventeen patients with nephritis due to mixed cryoglobulinaemia were submitted to regular haemodialysis in 11 and continuous ambulatory peritoneal dialysis in six after 145 ± 55 months from the onset of the disease. Four patients with very poor clinical conditions died within 6 months from the beginning of dialysis. The other 13 patients were followed for a mean period of 78.7 ± 41.6 months. The actuarial survival rate was 65% at 5 years. Both clinical and immunological signs of mixed cryoglobulinaemia reduced during dialysis but a long-lasting bum out was observed only in one patient. Two patients received a kidney graft. Mixed cryoglobulinaemia nephritis recurred in both of them respectively 5 and 10 months after transplantation. One patient lost his graft 13 months after transplantation because of chronic rejection. The other one still has a functioning kidney 48 months after renal transplantation. The life expectancy with dialysis for mixed cryoglobulinaemia patients is similar to that of patients with standard primary renal disease but some few patients with severe disease at the beginning of dialysis have a poor prognosis. Nephritis may recur after renal transplantation but this does not preclude per se a favourable course in the long term.

Original languageEnglish
Pages (from-to)1426-1430
Number of pages5
JournalNephrology Dialysis Transplantation
Volume9
Issue number10
Publication statusPublished - 1994

Fingerprint

Renal Replacement Therapy
Nephritis
Cryoglobulinemia
Dialysis
Kidney
Kidney Transplantation
Transplantation
Transplants
Continuous Ambulatory Peritoneal Dialysis
Life Expectancy
Renal Dialysis
Survival Rate

Keywords

  • Dialysis
  • Mixed cryoglobulinaemia
  • Nephritis
  • Transplantation

ASJC Scopus subject areas

  • Nephrology
  • Transplantation

Cite this

Tarantino, A., Moroni, G., Banfi, G., Manzoni, C., Segagni, S., & Ponticelli, C. (1994). Renal replacement therapy in cryoglobulinaemic nephritis. Nephrology Dialysis Transplantation, 9(10), 1426-1430.

Renal replacement therapy in cryoglobulinaemic nephritis. / Tarantino, A.; Moroni, G.; Banfi, G.; Manzoni, C.; Segagni, S.; Ponticelli, C.

In: Nephrology Dialysis Transplantation, Vol. 9, No. 10, 1994, p. 1426-1430.

Research output: Contribution to journalArticle

Tarantino, A, Moroni, G, Banfi, G, Manzoni, C, Segagni, S & Ponticelli, C 1994, 'Renal replacement therapy in cryoglobulinaemic nephritis', Nephrology Dialysis Transplantation, vol. 9, no. 10, pp. 1426-1430.
Tarantino A, Moroni G, Banfi G, Manzoni C, Segagni S, Ponticelli C. Renal replacement therapy in cryoglobulinaemic nephritis. Nephrology Dialysis Transplantation. 1994;9(10):1426-1430.
Tarantino, A. ; Moroni, G. ; Banfi, G. ; Manzoni, C. ; Segagni, S. ; Ponticelli, C. / Renal replacement therapy in cryoglobulinaemic nephritis. In: Nephrology Dialysis Transplantation. 1994 ; Vol. 9, No. 10. pp. 1426-1430.
@article{d00ed682f3ab4070adb952f6a9b303d3,
title = "Renal replacement therapy in cryoglobulinaemic nephritis",
abstract = "Seventeen patients with nephritis due to mixed cryoglobulinaemia were submitted to regular haemodialysis in 11 and continuous ambulatory peritoneal dialysis in six after 145 ± 55 months from the onset of the disease. Four patients with very poor clinical conditions died within 6 months from the beginning of dialysis. The other 13 patients were followed for a mean period of 78.7 ± 41.6 months. The actuarial survival rate was 65{\%} at 5 years. Both clinical and immunological signs of mixed cryoglobulinaemia reduced during dialysis but a long-lasting bum out was observed only in one patient. Two patients received a kidney graft. Mixed cryoglobulinaemia nephritis recurred in both of them respectively 5 and 10 months after transplantation. One patient lost his graft 13 months after transplantation because of chronic rejection. The other one still has a functioning kidney 48 months after renal transplantation. The life expectancy with dialysis for mixed cryoglobulinaemia patients is similar to that of patients with standard primary renal disease but some few patients with severe disease at the beginning of dialysis have a poor prognosis. Nephritis may recur after renal transplantation but this does not preclude per se a favourable course in the long term.",
keywords = "Dialysis, Mixed cryoglobulinaemia, Nephritis, Transplantation",
author = "A. Tarantino and G. Moroni and G. Banfi and C. Manzoni and S. Segagni and C. Ponticelli",
year = "1994",
language = "English",
volume = "9",
pages = "1426--1430",
journal = "Nephrology Dialysis Transplantation",
issn = "0931-0509",
publisher = "Oxford University Press",
number = "10",

}

TY - JOUR

T1 - Renal replacement therapy in cryoglobulinaemic nephritis

AU - Tarantino, A.

AU - Moroni, G.

AU - Banfi, G.

AU - Manzoni, C.

AU - Segagni, S.

AU - Ponticelli, C.

PY - 1994

Y1 - 1994

N2 - Seventeen patients with nephritis due to mixed cryoglobulinaemia were submitted to regular haemodialysis in 11 and continuous ambulatory peritoneal dialysis in six after 145 ± 55 months from the onset of the disease. Four patients with very poor clinical conditions died within 6 months from the beginning of dialysis. The other 13 patients were followed for a mean period of 78.7 ± 41.6 months. The actuarial survival rate was 65% at 5 years. Both clinical and immunological signs of mixed cryoglobulinaemia reduced during dialysis but a long-lasting bum out was observed only in one patient. Two patients received a kidney graft. Mixed cryoglobulinaemia nephritis recurred in both of them respectively 5 and 10 months after transplantation. One patient lost his graft 13 months after transplantation because of chronic rejection. The other one still has a functioning kidney 48 months after renal transplantation. The life expectancy with dialysis for mixed cryoglobulinaemia patients is similar to that of patients with standard primary renal disease but some few patients with severe disease at the beginning of dialysis have a poor prognosis. Nephritis may recur after renal transplantation but this does not preclude per se a favourable course in the long term.

AB - Seventeen patients with nephritis due to mixed cryoglobulinaemia were submitted to regular haemodialysis in 11 and continuous ambulatory peritoneal dialysis in six after 145 ± 55 months from the onset of the disease. Four patients with very poor clinical conditions died within 6 months from the beginning of dialysis. The other 13 patients were followed for a mean period of 78.7 ± 41.6 months. The actuarial survival rate was 65% at 5 years. Both clinical and immunological signs of mixed cryoglobulinaemia reduced during dialysis but a long-lasting bum out was observed only in one patient. Two patients received a kidney graft. Mixed cryoglobulinaemia nephritis recurred in both of them respectively 5 and 10 months after transplantation. One patient lost his graft 13 months after transplantation because of chronic rejection. The other one still has a functioning kidney 48 months after renal transplantation. The life expectancy with dialysis for mixed cryoglobulinaemia patients is similar to that of patients with standard primary renal disease but some few patients with severe disease at the beginning of dialysis have a poor prognosis. Nephritis may recur after renal transplantation but this does not preclude per se a favourable course in the long term.

KW - Dialysis

KW - Mixed cryoglobulinaemia

KW - Nephritis

KW - Transplantation

UR - http://www.scopus.com/inward/record.url?scp=0028088327&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028088327&partnerID=8YFLogxK

M3 - Article

VL - 9

SP - 1426

EP - 1430

JO - Nephrology Dialysis Transplantation

JF - Nephrology Dialysis Transplantation

SN - 0931-0509

IS - 10

ER -